Hong Kong General Merchandise and Department Stores Stock News

SEHK:1473
SEHK:1473Electronic

Pangaea Connectivity Technology (SEHK:1473) Stock Faces Thin 1.9% Margin Despite 36.1% Earnings Growth

Pangaea Connectivity Technology (SEHK:1473) has just posted its FY 2026 first half results, with revenue of HK$1.05b and basic EPS of HK$0.015, set against trailing twelve month figures of HK$2.23b in revenue and basic EPS of HK$0.037. Over recent periods the company has seen revenue move from HK$1.02b in 1H FY 2025 to HK$1.11b in 2H FY 2025 and HK$1.05b in 1H FY 2026, while basic EPS shifted from HK$0.0147 to HK$0.0162 and then HK$0.0151. This gives investors a clear view of how the top and...
SEHK:57
SEHK:57Machinery

Chen Hsong Holdings (SEHK:57) Stock Faces Margin Squeeze That Supports Bearish Narratives

Chen Hsong Holdings (SEHK:57) has opened FY 2026 with first half revenue of HK$1,211.5 million and basic EPS of HK$0.096, setting the tone for how the rest of the year might shape up after a period of softer profitability. Over the last few reporting halves, revenue has moved from HK$1,208.8 million in 1H FY 2025 to HK$1,385.9 million in 2H FY 2025, with EPS shifting from HK$0.103 to HK$0.142 along the way, so the latest print slots into a revenue range investors already know well even as EPS...
SEHK:1050
SEHK:1050Electronic

Karrie International Holdings (SEHK:1050) Stock Faces Mixed Views As Net Margin Reaches 7.8%

Karrie International Holdings (SEHK:1050) has just reported its FY 2026 first half results, with revenue of HK$1,608.7 million, basic EPS of HK$0.050, and trailing 12 month net income of HK$270.9 million and EPS of HK$0.133 framing the latest read on profitability. The company has seen revenue move from HK$1,526.7 million in 1H FY 2025 to HK$1,704.7 million in 2H FY 2025 and then HK$1,608.7 million in 1H FY 2026. Over the same periods, basic EPS has tracked in a tight range around HK$0.050,...
SEHK:1458
SEHK:1458Food

Discovering Undiscovered Gems in Global Markets June 2026

As global markets navigate a complex landscape marked by steady interest rates in the U.S., a significant rate hike in Japan, and mixed economic signals across regions, investors are increasingly focused on small-cap stocks that have shown resilience amidst these shifts. In this dynamic environment, identifying undiscovered gems often involves seeking companies with strong fundamentals and growth potential that can thrive despite broader market volatility.
SEHK:753
SEHK:753Airlines

Can Air China (SEHK:753) Justify Its P\E As Fresh Operating Data Lands?

Why Air China’s latest operating update matters for shareholders Air China (SEHK:753) has drawn market attention after releasing detailed operating results for May 2026 and the year to date, covering capacity, traffic, load factors, and both passenger and cargo volumes. These figures give investors a fresh snapshot of how intensively the airline is using its fleet, how full its planes are, and how passenger and cargo trends compare between the single month of May and the broader year to...
SEHK:522
SEHK:522Semiconductor

ASMPT (SEHK:522) Could Be 15% Overvalued As AI Packaging Orders Keep Rolling In

ASMPT (SEHK:522) drew investor attention after securing a repeat order for eight Firebird Thermo Compression Bonding tools from a leading integrated device manufacturer. This highlighted the continued use of its equipment in high volume chip production. See our latest analysis for ASMPT. Beyond this repeat order, ASMPT’s recent share price performance has been strong, with a 30 day share price return of 8.78%, a 90 day share price return of 87.31%, and a 1 year total shareholder return of...
SEHK:1211
SEHK:1211Auto

BYD (SEHK:1211) Could Be 50% Undervalued On Its Most Popular Narrative

BYD stock performance sets the stage for valuation questions BYD (SEHK:1211) has come under pressure recently, with the stock down about 17% over the past month and about 26% over the past 3 months, prompting fresh scrutiny of its current valuation. Those moves sit against a longer track record that includes a year to date decline of about 23% and a total return decline of about 41% over the past year, even as the company reports sizeable revenue and net income. See our latest analysis for...
SEHK:2513
SEHK:2513Software

Knowledge Atlas Technology (SEHK:2513) Following Musk AI Remarks Looks Pricey Against Fair Value

Knowledge Atlas Technology (SEHK:2513) drew fresh attention after Elon Musk publicly discussed China’s AI capabilities, linking them to the company’s progress, with Zhipu AI’s CEO responding that reaching leading global model quality “won't take that long.” See our latest analysis for Knowledge Atlas Technology. Beyond the high profile comments on China’s AI capabilities, Knowledge Atlas Technology’s recent AGM brought a new independent non executive director, a rebrand to Z.AI Co., Ltd., and...
SEHK:992
SEHK:992Tech

Lenovo Group (SEHK:992) Expands Hybrid AI Tools, Is It Still A Bargain?

Lenovo Group (SEHK:992) recently expanded its Hybrid AI Advantage portfolio, introducing new AI inferencing and agentic AI tools aimed at helping enterprises deploy AI agents more efficiently and at lower operating cost across devices and data centers. See our latest analysis for Lenovo Group. The recent Hybrid AI announcements, new tablet launch and a completed US$2b zero coupon convertible bond sit against a backdrop of strong momentum, with a 30-day share price return of 45.52% and a...
SEHK:1672
SEHK:1672Biotechs

Is Ascletis Pharma (SEHK:1672) Undervalued On FDA Clearance For ASC35?

Ascletis Pharma (SEHK:1672) has attracted investor attention after receiving U.S. FDA Investigational New Drug clearance for ASC35, a once-monthly dual GLP-1/GIP agonist that is being advanced into a Phase I obesity trial. See our latest analysis for Ascletis Pharma. The FDA IND clearance arrives after a volatile year for Ascletis Pharma, with the share price down 35.2% over the past month and 37.9% over three months, while still delivering a 3-year total shareholder return of 418.5% and a...
SEHK:9885
SEHK:9885Healthcare

June 2026's Top Penny Stock Opportunities In Global

Global markets have been influenced by key developments, such as the Federal Reserve's decision to hold interest rates steady and the Bank of Japan's rate hike to a 31-year high. Against this backdrop, penny stocks—often representing smaller or newer companies—continue to offer intriguing opportunities for investors seeking growth potential at lower price points. While the term "penny stocks" may seem outdated, these investments can still present valuable prospects when they exhibit strong...
SEHK:700
SEHK:700Interactive Media and Services

Tencent Holdings (SEHK:700) Stock Could Be 58.4% Below Fair Value After Recent Weakness

Recent Performance Snapshot for Tencent Holdings stock Tencent Holdings (SEHK:700) has drawn investor attention after a period where the stock declined 4.2% over the past day, 7.3% over the past week and about 6% over the past month. Over the past 3 months, Tencent Holdings is down about 17.9%, with the year to date return showing a decline of 33.4%. On a 1 year basis, the total return is down 17.6%, while the 3 year total return stands at 25.1% and the 5 year total return reflects a decline...
SEHK:1211
SEHK:1211Auto

3 AI Infrastructure Stocks With High Insider Ownership And Growth

Growth has become harder to find as major economies send mixed signals, from weak European PMIs and contracting UK services to patchy strength across Asia and Latin America. In this kind of stop start backdrop, many investors are looking for companies where management is clearly aligned with shareholders and analysts see room for further expansion. The Fast Growing Stocks With High Insider Ownership screener focuses on exactly that combination. It highlights businesses where insiders have...
SEHK:2161
SEHK:2161Pharmaceuticals

JBM (Healthcare) (SEHK:2161) Stock Faces Margin Slippage Question As Net Margin Eases To 24.1%

JBM (Healthcare) (SEHK:2161) has posted its FY 2026 first half results with revenue of HK$429.6 million and basic EPS of HK$0.141, setting the stage for how investors assess the latest move in profitability. The company has reported revenue of HK$398.9 million in FY 2025 H1, HK$383.3 million in FY 2025 H2, and HK$429.6 million in FY 2026 H1, while basic EPS was HK$0.116 in FY 2025 H1, HK$0.108 in FY 2025 H2, and HK$0.141 in the latest half. These figures sit against a slightly softer net...
SEHK:1138
SEHK:1138Oil and Gas

COSCO SHIPPING Energy Transportation (SEHK:1138) Stock Could Be 4.6% Below Fair Value After SSE 180 Addition

Why the SSE 180 Index Addition Matters for COSCO SHIPPING Energy Transportation COSCO SHIPPING Energy Transportation (SEHK:1138) was recently added to the SSE 180 Index, a move that can draw more attention from institutional investors and index-tracking funds. This index inclusion often leads to higher visibility in the domestic market, which can influence trading volumes and liquidity. For existing and potential shareholders, the change raises questions about how the stock’s fundamentals...
SEHK:6933
SEHK:6933Entertainment

Sino-Entertainment Technology Holdings And 2 Other Asian Penny Stocks To Consider

Amidst a backdrop of shifting monetary policies and mixed economic signals in Asia, investors are closely watching regional markets for opportunities. Penny stocks, often associated with smaller or emerging companies, continue to capture interest due to their potential for substantial growth when supported by strong financials. While the term "penny stock" may seem outdated, the investment potential remains significant as these companies can offer unique value propositions that larger firms...
SEHK:8030
SEHK:8030Consumer Finance

Asian Market Insights: 3 Penny Stocks With Market Caps Over US$30M

As the Asian markets navigate a complex landscape marked by geopolitical developments and monetary policy shifts, investors are on the lookout for opportunities that align with current economic conditions. Penny stocks, though often seen as relics of speculative trading, still offer potential when backed by strong financials and growth prospects. This article explores three penny stocks in Asia that stand out for their robust fundamentals, offering a unique opportunity for investors seeking...
SEHK:867
SEHK:867Pharmaceuticals

How NMPA Approval of First-in-Class Rabies Antibody Will Impact China Medical System (SEHK:867) Investors

China Medical System Holdings announced that its New Drug Application for Silevimig Injection, a fully human bispecific antibody for passive immunization after rabies exposure, was approved by China’s National Medical Products Administration on 22 June 2026, and the company obtained the drug registration certificate. This approval introduces the world’s first dual-epitope rabies bispecific antibody, adding an eighth commercialized innovative drug to the group’s portfolio and enhancing its...
SEHK:9969
SEHK:9969Biotechs

Extensive Orelabrutinib Data Across Regions Might Change The Case For Investing In InnoCare Pharma (SEHK:9969)

In June 2026, InnoCare Pharma reported that over 40 clinical studies of its BTK inhibitor orelabrutinib were presented at the European Hematology Association Congress, highlighting consistent efficacy and safety across multiple blood cancers and patient populations in the United States, Europe, and China. Beyond confirming strong responses in chronic lymphocytic leukemia and marginal zone lymphoma, the data suggested orelabrutinib may offer a differentiated safety profile and meaningful...